Skip to Content

Exponent/Xeinadin

M/22/004

Completed

Transaction details

The proposed acquisition by Exponent Private Equity LLP of Xeinadin Group Limited has been cleared by the Competition Consumer Protection Commission.
Case details
  • Notification date:24 January 2022
  • Publication date:24 January 2022
  • Economic sector:Professional, scientific & technical activities - N
  • Economic sub-sector:Legal & accounting - N.69
  • Simplified merger:Yes
  • Outcome:Cleared
Documents
Timetable

Phase One

  • Monday, 24 January, 2022 Notification received
  • Friday, 4 February, 2022 Third party submission deadline
  • Thursday, 28 April, 2022 Determination issued
Parties Involved

Exponent Private Equity LLP

Exponent is a limited liability partnership incorporated in England and Wales that makes private equity investments in businesses located in the United Kingdom, Ireland and across Europe. Exponent’s investments involve a range of different industry sectors, including healthcare, food, transportation, advertising, and finance.

 

Xeinadin Group Limited

Xeinadin is a financially consolidated group of accounting firms spread across the UK and Ireland that is ultimately owned by individuals who work in its member offices. Xeinadin offers accounting and bookkeeping, payroll, tax, audit and business consulting (including corporate finance and restructuring) services to entrepreneurs, small or medium enterprises with less than 250 full-time employees and not-for-profit organisations

Contacts
View all mergers